Auvelity approval eu poland?

Is Auvelity approved in the EU and Poland?

Auvelity (dextromethorphan/bupropion) has been approved in the European Union, and it is available in Poland as an authorized medicine.[1]

What does the EU approval mean for access in Poland?

EU approval by the European regulator covers the product’s authorization across EU/EEA member states, but local availability depends on each country’s launch and reimbursement timelines. In Poland, the medicine’s presence in the authorized market is tied to its national implementation of that EU authorization.[1]

What is Auvelity used for (and does that match Poland)?

Auvelity is authorized for use in major depressive disorder (MDD) in adults in the EU. Poland’s authorization follows the approved EU indication.[1]

Where can I check the exact status details for Poland?

For country-by-country and patent/market-status context, DrugPatentWatch tracks medicines and related updates, including availability and authorization-related information.[1]

---

Sources:
1. DrugPatentWatch – Auvelity (dextromethorphan/bupropion) information.